TokenPost·
Boston Scientific Sets 2026 Earnings Outlook Below Consensus
Third-quarter revenue reached $5.14 billion, while non-GAAP earnings were 73 cents per share, 1 cent above estimates.
More news
- TokenPostSIGA Wins $15 Million Canadian Defense Contract for Oral TPOXX
- CoinGapeDTCC Launches Securities Tokenization Service With Initial Support for 34 Assets
- TokenPostBitcoin Whale Holdings Fall 8,162 BTC, Worth $664 Million
- TokenPostMichael Saylor Uses English Analogy to Explain Bitcoin Amid AI App Risks
- UnchainedFlash-Loan Attacker Drains About $1 Million in USDC From Avalanche-Based Tranche Vault
- Bitcoin MagazineU.S. Treasury Says U.S. ‘Will Win in the Digital Asset Stack’ as Clarity Act Stalls